IsoRay highlights cesium-131 brachytherapy research
Medical isotope developer IsoRay is highlighting research that suggests the...Read more on AuntMinnie.comRelated Reading:
IsoRay touts prostate cancer treatment data
FDA responds to IsoRay's GammaTile 510(k)
Court approves IsoRay class-action settlement
IsoRay agrees to settle shareholder lawsuit
IsoRay revenue falls, net loss edges up in Q4
Source: AuntMinnie.com Headlines - Category: Radiology Source Type: news
More News: Brachytherapy | Cancer | Cancer & Oncology | Lawsuits | Legislation | Prostate Cancer | Radiology